A Comparison of Digitalis Use on Mortality and Morbidity Among Special Populations With Heart Failure Reduced Ejection Fractions

Journal of Cardiac Failure - United States
doi 10.1016/j.cardfail.2018.07.085
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Use of Potentially Harmful Drugs Among Medicare Beneficiaries With Heart Failure and Reduced Ejection Fraction: Impact on Readmissions and Mortality

Journal of Cardiac Failure
Cardiovascular MedicineCardiology
2019English

Prognosis of Heart Failure With Stable Mid-Range Ejection Fraction in Comparison to Heart Failure With Stable Reduced Ejection Fraction and Heart Failure With Stable Preserved Ejection Fraction

Journal of Cardiac Failure
Cardiovascular MedicineCardiology
2019English

Hydralazine/Isosorbide Dinitrate, Blood Pressure and Mortality in Patients With Heart Failure With Reduced Ejection Fraction

Journal of Cardiac Failure
Cardiovascular MedicineCardiology
2018English

Biomarkers of Inflammation in Heart Failure Patients With Reduced and Preserved Ejection Fractions: Multi-Ethnic Study of Atherosclerosis

Metabolism: Clinical and Experimental
EndocrinologyMetabolismDiabetes
2020English

Relation Between Therapy-Induced Changes in Natriuretic Peptide Levels and Long-Term Therapeutic Effects on Morbidity/Mortality in Patients With Heart Failure and Reduced Ejection Fraction

Journal of Cardiac Failure
Cardiovascular MedicineCardiology
2016English

Influence of Ejection Fraction on Cause-Specific Mortality in Heart Failure With Preserved Ejection Fraction

European Journal of Heart Failure
Cardiovascular MedicineCardiology
2017English

Comparison of Usefulness of SYNTAX Score in Heart Failure Patients With Preserved Ejection Fraction Versus Those With Reduced Ejection Fraction

Journal of Cardiac Failure
Cardiovascular MedicineCardiology
2015English

Large Animal Models of Heart Failure With Reduced Ejection Fraction (HFrEF)

Frontiers in Cardiovascular Medicine
Cardiovascular MedicineCardiology
2019English

Evaluation of the Effect of Sodium–glucose Co‐transporter 2 Inhibition With Empagliflozin on Morbidity and Mortality of Patients With Chronic Heart Failure and a Reduced Ejection Fraction: Rationale for and Design of the EMPEROR‐Reduced Trial

European Journal of Heart Failure
Cardiovascular MedicineCardiology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy